Nuwellis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nuwellis and other ETFs, options, and stocks.About NUWE
Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload.
CEOJohn L. Erb
CEOJohn L. Erb
Employees38
Employees38
HeadquartersEden Prairie, Minnesota
HeadquartersEden Prairie, Minnesota
Founded1999
Founded1999
Employees38
Employees38
NUWE Key Statistics
Market cap3.26M
Market cap3.26M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume57.75K
Average volume57.75K
High today$2.65
High today$2.65
Low today$2.22
Low today$2.22
Open price$2.52
Open price$2.52
Volume63.04K
Volume63.04K
52 Week high$25.95
52 Week high$25.95
52 Week low$0.19
52 Week low$0.19
Stock Snapshot
As of today, Nuwellis(NUWE) shares are valued at $2.25. The company's market cap stands at 3.26M, with a P/E ratio of -0.02.
During the trading session on 2025-12-13, Nuwellis(NUWE) shares reached a daily high of $2.65 and a low of $2.22. At a current price of $2.25, the stock is +1.4% higher than the low and still -15.1% under the high.
Trading activity shows a volume of 63.04K, compared to an average daily volume of 57.75K.
The stock's 52-week range extends from a low of $0.19 to a high of $25.95.
The stock's 52-week range extends from a low of $0.19 to a high of $25.95.
NUWE News
TipRanks 4d
Nuwellis announces presentation of data on broad utility of AquadexNuwellis (NUWE) announced the presentation of new real-world data from New York City’s Lenox Hill Hospital at the 2025 American Society of Nephrology, ASN, Kidn...
People also own
Based on the portfolios of people who own NUWE. This list is generated using Robinhood data, and it’s not a recommendation.